GT200100230A - Derivados de benzodiazepina como moduladores del receptor gaba a. - Google Patents
Derivados de benzodiazepina como moduladores del receptor gaba a.Info
- Publication number
- GT200100230A GT200100230A GT200100230A GT200100230A GT200100230A GT 200100230 A GT200100230 A GT 200100230A GT 200100230 A GT200100230 A GT 200100230A GT 200100230 A GT200100230 A GT 200100230A GT 200100230 A GT200100230 A GT 200100230A
- Authority
- GT
- Guatemala
- Prior art keywords
- receiver
- gaba
- benzodiazepin
- modulators
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS QUIMICOS DE LA FORMULA I, EN DONDE R1, R2 Y R3 SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. TAMBIEN SE REFIERE A SUS SALES DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLES. ESTOS COMPUESTOS PRESENTA UNA BUENA AFINIDAD PARA EL RECEPTOR GABA A ALFA5 Y POR CONSIGUIENTE SON UTILES DURANTE EL TRATAMIENTO DE ENFERMEDADES RELACIONADAS CON ESE RECEPTOR COMO POR EJEMPLO LA ENFERMEDAD DE ALZHEIMER.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00124332 | 2000-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200100230A true GT200100230A (es) | 2002-07-04 |
Family
ID=8170315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200100230A GT200100230A (es) | 2000-11-16 | 2001-11-15 | Derivados de benzodiazepina como moduladores del receptor gaba a. |
Country Status (41)
Country | Link |
---|---|
US (1) | US6743789B2 (es) |
EP (1) | EP1337535B1 (es) |
JP (1) | JP4088151B2 (es) |
KR (1) | KR100504300B1 (es) |
CN (1) | CN1191255C (es) |
AR (1) | AR031345A1 (es) |
AT (1) | ATE268776T1 (es) |
AU (2) | AU2002217007B2 (es) |
BG (1) | BG107817A (es) |
BR (1) | BR0115393A (es) |
CA (1) | CA2427576C (es) |
CZ (1) | CZ295256B6 (es) |
DE (1) | DE60103776T2 (es) |
DK (1) | DK1337535T3 (es) |
EC (1) | ECSP034607A (es) |
ES (1) | ES2220831T3 (es) |
GC (1) | GC0000375A (es) |
GT (1) | GT200100230A (es) |
HK (1) | HK1062442A1 (es) |
HR (1) | HRP20030360A2 (es) |
HU (1) | HUP0303281A3 (es) |
IL (1) | IL155813A0 (es) |
JO (1) | JO2359B1 (es) |
MA (1) | MA26962A1 (es) |
MX (1) | MXPA03004251A (es) |
MY (1) | MY141675A (es) |
NO (1) | NO324706B1 (es) |
NZ (1) | NZ525413A (es) |
PA (1) | PA8532401A1 (es) |
PE (1) | PE20020583A1 (es) |
PL (1) | PL362925A1 (es) |
PT (1) | PT1337535E (es) |
RU (1) | RU2278865C2 (es) |
SI (1) | SI1337535T1 (es) |
SK (1) | SK7232003A3 (es) |
TR (1) | TR200402073T4 (es) |
TW (1) | TWI239333B (es) |
UY (1) | UY27026A1 (es) |
WO (1) | WO2002040487A2 (es) |
YU (1) | YU35603A (es) |
ZA (1) | ZA200303435B (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6686352B2 (en) * | 2001-05-18 | 2004-02-03 | Hoffmann-La Roche Inc. | Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives |
US7626029B2 (en) * | 2003-06-19 | 2009-12-01 | Daiichi Pharmaceutical Co., Ltd. | Method of selectively introducing amino substituent |
WO2005060968A1 (en) | 2003-12-11 | 2005-07-07 | Sepracor Inc. | Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
WO2006020959A2 (en) | 2004-08-13 | 2006-02-23 | Amgen Inc. | Substituted benzofused heterocycles |
RU2007112675A (ru) * | 2004-10-12 | 2008-11-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | ПРОИЗВОДНЫЕ ИМИДАЗО[1,5-a]ТРИАЗОЛО[1,5-d]БЕНЗОДИАЗЕПИНА ДЛЯ ЛЕЧЕНИЯ КОГНИТИВНЫХ РАССТРОЙСТВ |
WO2006045429A1 (en) * | 2004-10-20 | 2006-05-04 | F. Hoffmann-La Roche Ag | Halogen substituted benzodiazepine derivatives |
JP4783375B2 (ja) | 2004-10-20 | 2011-09-28 | エフ.ホフマン−ラ ロシュ アーゲー | イミダゾベンゾジゼピン誘導体 |
JP4783380B2 (ja) | 2004-12-14 | 2011-09-28 | エフ.ホフマン−ラ ロシュ アーゲー | Gabaレセプタ調節物質としての四環系イミダゾ−ベンゾジアゼピン類 |
US8510055B2 (en) | 2005-08-03 | 2013-08-13 | The Johns Hopkins University | Methods for characterizing and treating cognitive impairment in aging and disease |
EP1924712B1 (en) * | 2005-08-03 | 2018-10-03 | The Johns Hopkins University | Methods for characterizing and treating cognitive impairment in aging and disease |
BRPI0617204A2 (pt) * | 2005-10-11 | 2011-07-19 | Hoffmann La Roche | derivados de imidazo benzodiazepina |
WO2007053596A1 (en) * | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US9156836B2 (en) * | 2008-05-16 | 2015-10-13 | Synta Pharmaceuticals Corp. | Tricyclic triazole compounds that modulate HSP90 activity |
CN102216304B (zh) | 2008-11-18 | 2014-07-09 | 弗·哈夫曼-拉罗切有限公司 | 二氢四氮杂苯并薁的烷基环己基醚 |
JP5452608B2 (ja) * | 2008-11-28 | 2014-03-26 | エフ.ホフマン−ラ ロシュ アーゲー | バソプレシン介在受容体アンタゴニストとしての使用のためのジヒドロテトラアザベンゾアズレンのアリールシクロヘキシルエーテル |
CU20090172A6 (es) | 2009-10-09 | 2011-10-05 | Facultad De Quimica Universidad De La Habana | Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular |
US9145372B2 (en) | 2010-11-15 | 2015-09-29 | Agenebio, Inc. | Pyridazine derivatives, compositions and methods for treating cognitive impairment |
US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
JP2015529254A (ja) * | 2012-09-21 | 2015-10-05 | ユーダブリューエム・リサーチ・ファウンデーション,インコーポレーテッド | 喘息における気道の過敏症及び炎症を制御するための新規なgabaaアゴニスト及び使用方法 |
CA3123897C (en) | 2013-12-20 | 2024-02-06 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
CA2990004C (en) * | 2015-06-19 | 2024-04-23 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
US10059718B2 (en) * | 2016-01-04 | 2018-08-28 | Tabomedex Biosciences, LLC | Fused quadracyclic compounds, compositions and uses thereof |
US10973479B2 (en) | 2016-05-16 | 2021-04-13 | Canon Medical Systems Corporation | X-ray diagnosis apparatus, X-ray diagnosis apparatus controlling method, and X-ray diagnosis system |
US20180170941A1 (en) * | 2016-12-19 | 2018-06-21 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
US11505555B2 (en) | 2016-12-19 | 2022-11-22 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
KR102512548B1 (ko) | 2017-12-22 | 2023-03-22 | 삼성디스플레이 주식회사 | 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물 |
JP2021528427A (ja) * | 2018-06-19 | 2021-10-21 | エージンバイオ, インコーポレイテッド | 認知障害を処置するためのベンゾジアゼピン誘導体、組成物および方法 |
KR102151969B1 (ko) * | 2019-12-11 | 2020-09-04 | 주식회사 지투비 | 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창 |
CN112979658B (zh) * | 2021-02-22 | 2022-05-31 | 南湖实验室 | 一种氟马西尼的制备方法 |
WO2024039886A1 (en) | 2022-08-19 | 2024-02-22 | Agenebio, Inc. | Benzazepine derivatives, compositions, and methods for treating cognitive impairment |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK174086D0 (da) | 1986-04-16 | 1986-04-16 | Ferrosan As | Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme |
TW201311B (es) | 1991-06-17 | 1993-03-01 | Hoffmann La Roche |
-
2001
- 2001-11-07 TW TW090127658A patent/TWI239333B/zh not_active IP Right Cessation
- 2001-11-08 JP JP2002543495A patent/JP4088151B2/ja not_active Expired - Fee Related
- 2001-11-08 US US10/007,883 patent/US6743789B2/en not_active Expired - Fee Related
- 2001-11-08 DE DE60103776T patent/DE60103776T2/de not_active Expired - Lifetime
- 2001-11-08 WO PCT/EP2001/012887 patent/WO2002040487A2/en active IP Right Grant
- 2001-11-08 AU AU2002217007A patent/AU2002217007B2/en not_active Ceased
- 2001-11-08 PT PT01996541T patent/PT1337535E/pt unknown
- 2001-11-08 EP EP01996541A patent/EP1337535B1/en not_active Expired - Lifetime
- 2001-11-08 ES ES01996541T patent/ES2220831T3/es not_active Expired - Lifetime
- 2001-11-08 MX MXPA03004251A patent/MXPA03004251A/es active IP Right Grant
- 2001-11-08 HU HU0303281A patent/HUP0303281A3/hu unknown
- 2001-11-08 BR BR0115393-5A patent/BR0115393A/pt not_active IP Right Cessation
- 2001-11-08 SK SK723-2003A patent/SK7232003A3/sk unknown
- 2001-11-08 CA CA002427576A patent/CA2427576C/en not_active Expired - Fee Related
- 2001-11-08 KR KR10-2003-7006609A patent/KR100504300B1/ko not_active IP Right Cessation
- 2001-11-08 SI SI200130125T patent/SI1337535T1/xx unknown
- 2001-11-08 IL IL15581301A patent/IL155813A0/xx unknown
- 2001-11-08 YU YU35603A patent/YU35603A/sh unknown
- 2001-11-08 AT AT01996541T patent/ATE268776T1/de not_active IP Right Cessation
- 2001-11-08 CZ CZ20031597A patent/CZ295256B6/cs not_active IP Right Cessation
- 2001-11-08 RU RU2003116895/04A patent/RU2278865C2/ru not_active IP Right Cessation
- 2001-11-08 PL PL01362925A patent/PL362925A1/xx not_active Application Discontinuation
- 2001-11-08 DK DK01996541T patent/DK1337535T3/da active
- 2001-11-08 NZ NZ525413A patent/NZ525413A/en unknown
- 2001-11-08 CN CNB018189415A patent/CN1191255C/zh not_active Expired - Fee Related
- 2001-11-08 AU AU1700702A patent/AU1700702A/xx active Pending
- 2001-11-08 TR TR2004/02073T patent/TR200402073T4/xx unknown
- 2001-11-12 JO JO2001183A patent/JO2359B1/en active
- 2001-11-13 GC GCP20011724 patent/GC0000375A/en active
- 2001-11-14 PE PE2001001135A patent/PE20020583A1/es not_active Application Discontinuation
- 2001-11-15 MY MYPI20015253A patent/MY141675A/en unknown
- 2001-11-15 GT GT200100230A patent/GT200100230A/es unknown
- 2001-11-15 UY UY27026A patent/UY27026A1/es not_active Application Discontinuation
- 2001-11-15 AR ARP010105323A patent/AR031345A1/es not_active Application Discontinuation
- 2001-11-15 PA PA20018532401A patent/PA8532401A1/es unknown
-
2003
- 2003-05-05 ZA ZA200303435A patent/ZA200303435B/en unknown
- 2003-05-07 HR HR20030360A patent/HRP20030360A2/hr not_active Application Discontinuation
- 2003-05-15 EC EC2003004607A patent/ECSP034607A/es unknown
- 2003-05-15 NO NO20032208A patent/NO324706B1/no unknown
- 2003-05-16 BG BG107817A patent/BG107817A/bg unknown
- 2003-05-16 MA MA27163A patent/MA26962A1/fr unknown
-
2004
- 2004-07-21 HK HK04105348A patent/HK1062442A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200100230A (es) | Derivados de benzodiazepina como moduladores del receptor gaba a. | |
GT200100137A (es) | Pro-drogas de derivados de 4-fenil-piridina. | |
GT200200122A (es) | Imidazotriazinas | |
GT200300219A (es) | Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos | |
GT200100148A (es) | Derivados de 4-fenil-piridina. | |
DOP2006000169A (es) | Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
UY26872A1 (es) | Derivados de la 4- fenil piridina | |
GT200100151A (es) | Derivados de 3-indolil-4-fenil-1h-pirrol-2,5-dione como inhibidores de glucogeno sintasa quinasa-3b. | |
DK1689721T3 (da) | Aminopyrazolderivater som GSK-3-ihibitorer | |
CY1108514T1 (el) | Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων | |
CR6726A (es) | Compuestos azapoliciclicos condensados con arilo | |
GT200100155A (es) | Derivados de piperazina. | |
GT200400076A (es) | Ligandos de receptores de cannabinoides y sus usos | |
GT200100183A (es) | Derivados de quinolina y quinazolina. | |
DOP2009000258A (es) | Compuestos amino-heterociclicos | |
GT200300226A (es) | 4-piperazinilbencenosulfonilindoles y usos de los mismos | |
PA8627201A1 (es) | Compuestos de imidazol para el tratamiento de trastornos neurodegenerativos | |
UY26782A1 (es) | Derivados del benzotiazol | |
MXPA05010293A (es) | 4-amino[1,2,4]triazolo[4,3-a]quinoxalinas sustituidas. | |
DK1641454T3 (da) | Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere | |
UA83691C2 (ru) | Применение замещенных 2-аминотетралинов для упреждающего лечения болезни паркинсона | |
MXPA05013628A (es) | Pirazolo[3,4-b]piridin-6-onas como inhibidores de gsk-3. | |
AR028705A1 (es) | Bis-arilsulfonas | |
ECSP088966A (es) | Agonistas del receptor muscarínico que son efectivos en el tratamiento del dolor, la enfermedad de alzheimer y la esquizofrenia | |
CY1110788T1 (el) | Διαγονιδιακα ζωα τα οποια παρουσιαζουν σημαντικες διαταραχες σχετικες με την νοσο alzheimer |